NVO
Novo Nordisk A/S
NYSE · DKHealthcareDrug Manufacturers - General
$50.05-0.55%
Price as of Jul 20, 2026
NVO ownership
Novo Nordisk A/S ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Institutional activity (13F)
How institutions changed their NVO positions over the last 6 months (SEC Form 13F).
Increased
941
New positions
346
Reduced
1047
Sold out
422
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 31.0M | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 20.1M | May 15, 2026 |
| DODGE & COX | New Position | 19.3M | May 14, 2026 |
| LOOMIS SAYLES & CO L P | Increased | 17.1M | Feb 12, 2026 |
| LOOMIS SAYLES & CO L P | Reduced | 17.0M | May 14, 2026 |
| FRANKLIN RESOURCES INC | Increased | 16.1M | May 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 15.4M | Feb 17, 2026 |
| FRANKLIN RESOURCES INC | Increased | 14.7M | Feb 11, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 13.4M | Feb 3, 2026 |
| JANE STREET GROUP, LLC | Reduced | 12.9M | May 12, 2026 |
| MORGAN STANLEY | Increased | 12.8M | Feb 13, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 11.9M | Feb 17, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Increased | 11.8M | May 13, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Reduced | 11.2M | Feb 11, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 11.1M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.